0001613377-18-000021.txt : 20181019 0001613377-18-000021.hdr.sgml : 20181019 20181019105713 ACCESSION NUMBER: 0001613377-18-000021 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181017 FILED AS OF DATE: 20181019 DATE AS OF CHANGE: 20181019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PASCALE ADAM CENTRAL INDEX KEY: 0001613377 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-27072 FILM NUMBER: 181129659 MAIL ADDRESS: STREET 1: 600 MAIN STREET STREET 2: SUITE 2 CITY: RIVERTON STATE: NJ ZIP: 08077 FORMER NAME: FORMER CONFORMED NAME: Pascale Adam DATE OF NAME CHANGE: 20140710 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEMISPHERX BIOPHARMA INC CENTRAL INDEX KEY: 0000946644 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 520845822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2117 SW HIGHWAY 484 CITY: OCALA STATE: FL ZIP: 32801 BUSINESS PHONE: 215-988-0080 MAIL ADDRESS: STREET 1: 2117 SW HIGHWAY 484 CITY: OCALA STATE: FL ZIP: 32801 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-10-17 0 0000946644 HEMISPHERX BIOPHARMA INC HEB 0001613377 PASCALE ADAM 600 MAIN STREET SUITE 2 RIVERTON NJ 08077 0 1 0 0 CFO Options to buy Common Stock 0.22 2018-10-17 4 A 0 94697 0 A 2018-10-17 2028-10-17 Common Stock 94697 94697 D This option is being issued to senior management in exchange for a voluntary 50% deferral in salary. Adam Pascale 2018-10-19